Olon

📍 Meet us at CPHI Korea 2026! We are excited to announce that we will be exhibiting at CPHI Korea 2026 in Seoul, one of Asia's leading pharmaceutical industry events. 👉 Visit us at Booth K40 to explore collaboration opportunities, discuss industry trends, and discover how we can support your pharmaceutical and healthcare needs. We look forward to meeting partners, customers, and industry professionals from around the world. #CPHIKorea2026 #Pharma #LifeSciences

Bringing complex molecules from development to commercial manufacturing requires more than technical expertise, it requires seamless integration across disciplines. We support pharmaceutical and biotech companies with end-to-end capabilities spanning Chemistry, Biotech and Industrial Manufacturing. By connecting these competencies under one organization, we help streamline development, enable efficient scale-up and support reliable manufacturing at every stage of the product lifecycle. Because successful innovation depends not only on breakthrough science, but also on the ability to manufacture it at scale. #CDMO #Biotech #Chemistry #ScaleUp #Innovation

🆕 Olon Expands Concord, Ohio Site, Doubling US Manufacturing Capacity ▶️ Olon has completed a major expansion at its Concord, #Ohio facility, doubling production capacity and strengthening the site's role as a US manufacturing hub within its global development network. Historically focused on chemical synthesis, process development, and early-stage manufacturing, the #Concord site has continuously evolved to meet the growing needs of pharmaceutical and #biotech customers. The completed expansion doubles the facility’s overall production capacity, significantly enhancing its commercial manufacturing capabilities while preserving its established strengths in development and scale-up. (...) Get more information on #CMI online: https://lnkd.in/dKVs9ycY

Big things don't happen alone. Collaboration isn't just a value we talk about, it's the engine behind every milestone we reach. When our teams work in sync, and when we partner closely with our clients and suppliers, something remarkable happens: innovation becomes a natural outcome, not a goal to chase. We're proud of where this philosophy has taken us, and even more excited about where it's heading. #OlonValues #BetterTogether #Peoplefirst

🏭❗Olon just doubled production capacity at its Concord, Ohio site... but the bigger story is what that unlocks for small-molecule programs. The expanded facility strengthens Olon USA’s ability to support customers across the full manufacturing journey: • Process development and scale-up • Early-stage through commercial manufacturing • Integrated U.S. and European supply capabilities • Recent FDA inspections completed with no observations This is more than a capacity expansion. For sponsor-side biotech and pharma teams, the real value is continuity, the ability to move a program forward without rebuilding the manufacturing strategy at every stage. More capacity matters. But so do regulatory performance, technical transferability, commercial readiness, and access to a resilient manufacturing network. By connecting its expanded U.S. capabilities with its European operations, Olon is positioning the Concord site as a more complete end-to-end CDMO solution for increasingly complex small-molecule programs. At Pharma Connect Navigator, we track expansions like this because CDMO capabilities are constantly changing and yesterday’s understanding of a partner may no longer reflect what they can support today. #SmallMolecules #CDMO #PharmaManufacturing #CMC #ProcessDevelopment #ScaleUp #CommercialManufacturing #Biotech #Pharma #Olon #CMO

Milan, Italy-based Olon, a company focused on the development and production of active pharmaceutical ingredients (#APIs), has completed an expansion of its Concord, Ohio manufacturing site, doubling production capacity and increasing the commercial manufacturing capabilities of Olon USA as demand grows for U.S.-based #biopharma manufacturing. The Concord facility supports chemical synthesis, process development, early-stage manufacturing, and commercial production for #pharmaceutical and #biotechnology companies. According to the announcement, the expansion allows the site to support projects from process development and scale-up through commercial supply. The company said recent #FDA inspections of the facility were completed without observations. Read more: https://lnkd.in/g5Xud4sq #PharmaManufacturing #CDMO #APIs #DrugSubstance #PharmaceuticalManufacturing #USManufacturing #PharmaIndustry #ProcessDevelopment

Olon has announced the completion of a major expansion at its Concord, Ohio facility. https://lnkd.in/evCCDSGr #expansion #pharma #manufacturing

Olon has completed a major expansion of its Concord, Ohio facility, further strengthening its role within the Group's global manufacturing network. The investment doubles the site's manufacturing capacity, enhances its integrated development and commercial manufacturing capabilities, and reinforces Olon's ability to support pharmaceutical and biotechnology companies across the full product lifecycle. Olon USA Read the full press release: https://lnkd.in/dWxAWUXX #Olon #PharmaceuticalManufacturing #API

Innovation is shaping the next generation of CDMO services. By embracing emerging technologies, the pharmaceutical industry can enhance efficiency, quality, and sustainability throughout the development and manufacturing journey. At Olon, innovation is part of our commitment to delivering value to our partners. Contact our team to learn more. #CDMO #Innovation #Pharma

Hi from the Olon team at BOS Basel! We're enjoying meeting so many great people and having inspiring conversations throughout the event. If you're attending the exhibition, there's still time to stop by and say hello. We'd love to meet you, chat, and explore new opportunities together. See you at BOS Basel, Booth #68! #BOSBasel #Biotech #CDMO